Source: PR Newswire

Press Release: BERG : BERG to Present Latest Research to Improve Pancreatic Treatment at The European Society for Medical Oncology (ESMO) 2021 Congress

FRAMINGHAM, Mass., Sept. 16, 2021 /PRNewswire/ -- BERG, a clinical-stage biotech that employs patient biology and artificial intelligence (AI) to research diseases and develop innovative treatments, today announced its participation at the European Society for Medical Oncology (ESMO) 2021...

Read full article »

BERG's Competitors | BERG's News | BERG's Financials

Followers on Owler

Est. Annual Revenue

$5.0-25M

Est. Employees

100-250

President & CEO

Niven R. Narain

CEO Approval Rating

89/100

BERG is a Massachusetts-based biotechnology company that offers solutions such as AI-powered drug discovery and research for industries including healthcare and pharmaceuticals.